Salvage or adjuvant radiation therapy: Counseling patients on the benefits

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 8, Issue 2, 2010, Pages 228-237

  Nielsen, Matthew E ^a   Trock, Bruce J ^b   Walsh, Patrick C ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Adjuvant radiotherapy; Generalizability; Prostate cancer; Risk stratification; Salvage radiotherapy

Indexed keywords

CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RECURRENT CANCER; REVIEW; SALVAGE THERAPY;

EID: 77649114450     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2010.0015     Document Type: Review

References (23)

1. Han M, Partin AW, Pound CR, et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001;28:555-565.
2. Pound CR, Partin AW, Eisenberger MA, et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281:1591-1597.
3. Mohler J, Amling CL, Bahnson RR, et al. NCCN clinical practice guidelines in oncology: prostate cancer. Version 2, 2009. Available at: http://www.nccn.org/professionals/physician-gls. Accessed December 10, 2009.
4. Bolla M, van Poppel H, Collette L, et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005;366:572-578.
5. Thompson IM Jr, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 2006;296:2329-2335.
6. Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol 2009;181:956-962.
7. Wiegel T, Bottke D, Steiner U, et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol 2009;27:2924-2930.
8. Trock BJ, Han M, Freedland SJ, et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 2008;299:2760-2769.
9. Wiegel T, Lohm G, Bottke D, et al. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome - results of a retrospective study. Int J Radiat Oncol Biol Phys 2009;73:1009-1016.
10. Swanson GP, Hussey MA, Tangen CM, et al. Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794. J Clin Oncol 2007;25:2225-2229.
11. Van der Kwast TH, Bolla M, Van Poppel H, et al. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J Clin Oncol 2007;25:4178-4186.
12. Porter CR, Capitanio U, Perrotte P, et al. Adjuvant radiotherapy after radical prostatectomy shows no ability to improve rates of overall and cancer-specific survival in a matched case-control study. BJU Int 2009;103:597-602.
13. Ornstein DK, Colberg JW, Virgo KS, et al. Evaluation and management of men whose radical prostatectomies failed: results of an international survey. Urology 1998;52:1047-1054.
14. Grossfeld GD, Stier DM, Flanders SC, et al. Use of second treatment following definitive local therapy for prostate cancer: data from the caPSURE database. J Urol 1998;160:1398-1404.
15. Stephenson AJ, Shariat SF, Zelefsky MJ, et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004;291:1325-1332.
16. Katz MS, Zelefsky MJ, Venkatraman ES, et al. Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. J Clin Oncol 2003;21:483-489.
17. Stephenson AJ, Scardino PT, Kattan MW, et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 2007;25:2035-2041. Erratum in: J Clin Oncol 2007;25:4153.
18. Van Cangh PJ, Richard F, Lorge F, et al. Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study. J Urol 1998;159:164-166.
19. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008;358:1250-1261.
20. Nieder AM, Porter MP, Soloway MS. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. J Urol 2008;180:2005-2009.
21. Brenner DJ, Curtis RE, Hall EJ, et al. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000;88:398-406.
22. Parker C, Sydes MR. Resolving the optimal timing of radiotherapy after radical prostatectomy: the need for further research. J Clin Oncol 2008;26:e3.
23. Abramowitz MC, Pollack A. Postprostatectomy radiation therapy for prostate cancer. Semin Radiat Oncol 2008;18:15-22.